Results 151 to 160 of about 9,369 (213)

Single-Dose Liposomal Amphotericin Plus Fluconazole and Flucytosine for Cryptococcal Meningitis at a US Public Hospital.

open access: yesJAMA Netw Open
Clark D   +9 more
europepmc   +1 more source

High mortality and amphotericin B-related nephrotoxicity in cerebral cryptococcosis in a low-resource neurology referral center: a prospective cohort study. [PDF]

open access: yesFront Neurol
Lobo Requena JY   +6 more
europepmc   +1 more source

In Vitro Antifungal Combination of Flucytosine with Amphotericin B, Voriconazole, or Micafungin against Candida auris Shows No Antagonism [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2019
International audienceCandida auris is an emerging, multidrug-resistant pathogen responsible for invasive hospital-acquired infections. Flucytosine is an effective anti- Candida species drug, but which cannot be used as a monotherapy because of the risk ...
Anuradha Chowdhary   +2 more
exaly   +2 more sources

Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients [PDF]

open access: yesJournal of Infectious Diseases, 2013
Background. Cryptococcal meningoencephalitis is a lethal infection with relatively few therapeutic options. The optimal dosage of liposomal amphotericin B (LAmB) alone or in combination with flucytosine is not known.Methods.
Thomas Harrison   +2 more
exaly   +2 more sources

Flucytosine

Drug and Therapeutics Bulletin, 1975
Flucytosine (5-fluorocytosine; 5FC; Alcobon - Roche) is a synthetic antifungal drug which is active when given orally. It is an analogue of the pyrimidine base cytosine, and probably acts by being deaminated to 5-fluorouracil which behaves as a pyrimidine antimetabolite during nucleic acid synthesis.1
openaire   +3 more sources

Home - About - Disclaimer - Privacy